Hormone Therapy for Prostate Cancer Linked to Heart Risks (HealthDay)

October 10, 2007 – 6:41 pm | posted in Public Health

HealthDay - TUESDAY, Oct. 9 (HealthDay News) — Prostate cancer patients
receiving androgen-deprivation therapy, a common form of hormone treatment
proven to slow tumor growth and prolong life, may face a nearly threefold
higher risk of dying from heart disease, a new study suggests.

ShareThis

Also Read

  • 3 New Lung Cancer Genes Identified (HealthDay)
  • More Fiber, Less Fat Help Prevent Ovarian Cancer (HealthDay)
  • Drop In Breast Cancer Incidence Linked To Hormone Use, Not Mammograms
  • New Classification Better Identifies Prostate Cancer Patients To Benefit From Hormone Therapy
  • Bone Loss Caused From Prostate Cancer Treatment Can Be Prevented By Walking
  • Measuring Calcium Intake Can Help To Identify Osteoporosis In Men With Prostate Cancer
  • Additional Hormone Therapy Use After Radiation For Some Prostate Cancers Extends Survival
  • Prostate cancer killed 140 N.H. men in 2006
  • Ovarian cancer and ER/PR testing?
  • Prostate Cancer Awareness Week To Screen Thousands

    • You must be logged in to post a comment.